Refocusing Research Efforts to Other Areas of the Body ...

Families with rare gene mutations that cause Alzheimer's in middle age are giving scientists a unique window on the disease, ...

New blood tests measuring p-tau217 levels show promise for predicting Alzheimer's risk years before symptoms appear, though ...

Migraine is linked to a 30% lower risk for dementia and a 42% lower risk for Alzheimer’s disease than not having migraine, a ...

Lecanemab, sold under the name Leqembi, is a monoclonal antibody therapy for Alzheimer's disease that clears toxic amyloid plaques and delays cognitive decline. Researchers from VIB and KU Leuven ...

People who have difficulty breathing during sleep may be more vulnerable to the brain changes associated with Alzheimer’s ...

A UNLV researcher has release his latest findings on the development of a drug to cure Alzheimer's over the last 10 years.

Potentially more than 90% of Alzheimer's disease cases would not occur without the contribution of a single gene (APOE), according to a new analysis led by UCL researchers. The scientists also found ...

By 2030, the population in the United States aged 65 and older is expected to reach 71 million or about 20% of Americans.